Cerus (CERS) Shares Outstanding (Weighted Average) (2010 - 2026)
Cerus' (CERS) quarterly Shares Outstanding (Weighted Average) came in at $194.1 million in Q1 2026, up 3.78% year-on-year from $187.1 million in Q1 2025, and up 1.86% quarter-over-quarter from $190.6 million in Q4 2025.
Cerus (CERS) Shares Outstanding (Weighted Average) (2010 - 2026) Analysis & Trends
Cerus has disclosed Shares Outstanding (Weighted Average) across 17 years of filings, most recently posting $194.1 million for Q1 2026.
- Shares Outstanding (Weighted Average) for Q1 2026 came in at $194.1 million, up 3.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $194.1 million (up 3.78% YoY), and the FY2025 annual result was $190.6 million, up 3.27% from the prior year.
- Shares Outstanding (Weighted Average) came in at $194.1 million for Q1 2026 at Cerus, up from $190.6 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $194.1 million in Q1 2026 to a low of $174.5 million in Q1 2022.
- The 5-year median for Shares Outstanding (Weighted Average) is $182.1 million (2024), against an average of $183.0 million.
- Across the five-year window, Shares Outstanding (Weighted Average) grew 2.11% in 2023 and climbed 4.23% in 2025, its largest moves.
- Cerus' Shares Outstanding (Weighted Average) stood at $176.5 million in 2022, then gained by 2.11% to $180.3 million in 2023, then gained by 2.38% to $184.6 million in 2024, then gained by 3.27% to $190.6 million in 2025, then advanced by 1.86% to $194.1 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $194.1 million (Q1 2026), $190.6 million (Q4 2025), and $191.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 579.20 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 456.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 385.10 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Cerus | 496.03 Mn | 416.34 Mn | 27.89 Mn | 194.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 194.14 Mn |
| Dec 31, 2025 | 190.59 Mn |
| Sep 30, 2025 | 191.83 Mn |
| Jun 30, 2025 | 191.30 Mn |
| Mar 31, 2025 | 187.07 Mn |
| Dec 31, 2024 | 184.56 Mn |
| Sep 30, 2024 | 184.17 Mn |
| Jun 30, 2024 | 183.54 Mn |
| Mar 31, 2024 | 182.09 Mn |
| Dec 31, 2023 | 180.27 Mn |
| Sep 30, 2023 | 179.95 Mn |
| Jun 30, 2023 | 179.45 Mn |
| Mar 31, 2023 | 178.27 Mn |
| Dec 31, 2022 | 176.55 Mn |
| Sep 30, 2022 | 176.23 Mn |
| Jun 30, 2022 | 175.72 Mn |
| Mar 31, 2022 | 174.48 Mn |
| Dec 31, 2021 | 171.28 Mn |
| Sep 30, 2021 | 170.67 Mn |
| Jun 30, 2021 | 170.04 Mn |